310
Y. Zeng et al. / Carbohydrate Research 338 (2003) 307–311
400 mm) of silica gel (100–200 mesh) with EtOAc–
petroleum ether (60–90 °C) as the eluent. Solutions
were concentrated at B60 °C under reduced pressure.
H), 4.17–4.06 (m, 3 H), 3.95 (m, 1 H), 3.81–3.77 (m, 4
H), 3.59–3.53 (m, 2 H), 2.16 (s, 3 H, CH3CO), 2.10 (s,
3 H, CH3CO), 2.08 (s, 6 H, 2 CH3CO), 2.06 (s, 3 H,
CH3CO), 2.04 (s, 3 H, CH3CO). Anal. Calcd for
C34H44O18: C, 55.14; H, 5.95. Found: C, 55.01; H, 5.80.
3.2. General procedure for deallylation to prepare
acceptors
3.6. 4-Methoxyphenyl 2,4,6-tri-O-acetyl-3-O-allyl-a-D-
To a solution of 4a (1.2 g, 1.7 mmol) or 4b (1.85 g, 2.6
mmol) in MeOH was added PdCl2 (60 mg). After
stirring for several h at rt, TLC indicated that the
reaction was complete. The mixture was filtered, and
the combined filtrate and washings were concentrated
to dryness. The resultant residue was purified by flash
chromatography to give acceptor 5 (931 mg, 82%) or 7
(1.48 g, 85%).
glucopyranosyl-(13)-2,4,6-tri-O-acetyl-b-
D-gluco-
pyranoside (4a)
Donor 3 (2.50 g, 5 mmol) was coupled with acceptor 2
(2.08 g, 5 mmol) to give 4a (2.05 g, 55%): [h]D +44.2°
1
(c 0.6, CHCl3); H NMR (CDCl3): l 6.93–6.79 (m, 4
H, C6H4), 5.78 (m, 1 H, ꢀCHꢁ), 5.27 (d, 1 H, J 4.0 Hz,
a-H-1), 5.27–5.11 (m, 4 H), 5.05 (t, 1 H, J 9.6 Hz), 4.80
(d, 1 H, J 8.0 Hz, b-H-1), 4.70 (dd, 1 H, J 3.4, 10.4 Hz,
H-2%), 4.24–3.95 (m, 8 H), 3.73 (s, 3 H, CH3O), 3.74 (m,
1H), 3.72 (m, 1 H), 2.11 (s, 3 H, CH3CO), 2.10 (s, 3 H,
CH3CO), 2.08 (s, 3 H, CH3CO), 2.07 (s, 3 H, CH3CO),
2.06 (s, 3 H, CH3CO), 2.04 (s, 3 H, CH3CO). 13C NMR
(CDCl3): l 170.65, 170.65, 170.65, 169.97, 169.94,
169.62, 156.00, 152.10, 134.43, 118.69, 116.69, 114.68,
100.65 (b-C-1, JC1ꢀH1 161 Hz), 96.05 (a-C-1, JC1ꢀH1 176
Hz), 76.25, 73.96, 73.17, 72.18, 71.88, 70.30, 69.47,
68.42, 62.12, 61.70, 55.71, 20.93. Anal. Calcd for
C34H44O18: C, 55.14; H, 5.95. Found: C, 54.95; H, 5.80.
3.3. General procedure for preparation of donors
Oxidative cleavage of 1-OMP of 4a (3.08 g, 4.16 mmol)
or 4b (2.20 g, 2.97 mmol) was carried out with CAN
(4.5 equiv) in 4:1 CH3CN–H2O at rt for 30 min. The
reaction mixture was diluted with water, and extracted
with CH2Cl2. The extracts were washed with water,
satd aq Na2CO3 and satd aq NaCl. The organic phase
was dried over anhyd Na2SO4, then concentrated to
dryness. Purification of the residue on a silica gel
column gave disaccharide with the 1-OH free. A mix-
ture of the product, trichloroacetonitrile, and DBU in
dry CH2Cl2 was stirred for 3 h and then concentrated.
The residue was purified by flash chromatography read-
ily afforded 9 (2.46 g, 76% for two steps) or 10 (1.73 g,
75% for two steps).
3.7. 4-Methoxyphenyl 2,4,6-tri-O-acetyl-3-O-allyl-b-
glucopyranosyl-(13)-2,4,6-tri-O-acetyl-a- -gluco-
-glucopyranoside
D-
D
pyranosyl-(13)-2,4,6-tri-O-acetyl-b-
D
(6)
3.4. General procedure for the glycosidations
Compound 6 was obtained (185 mg, 84%) by coupling
of donor 3 (100 mg, 0.21 mmol) with acceptor 5 (150
mg, 0.21 mmol), or obtained (130 mg, 62%) from donor
10 (160 mg, 0.20 mmol) and acceptor 2 (85 mg, 0.20
The mixture of donor and acceptor was dried together
under high vacuum for 2 h, then dissolved in anhyd
CH2Cl2. TMSOTf (0.05 equiv) was added dropwise at
−20 °C with N2 protection. The reaction mixture was
stirred for 3 h, during which time the temperature was
gradually raised to ambient temperature. Then the mix-
ture was neutralized with Et3N. Concentration of the
reaction mixture, followed by purification on a silica gel
column, gave the desired products.
1
mmol): [h]D +6.7° (c 0.86, CHCl3); H NMR (CDCl3):
l 6.93–6.80 (m, 4 H, C6H4), 5.74 (m, 1 H, ꢀCHꢁ), 5.27
(t, 1 H, J 9.6 Hz), 5.25 (t, 1 H, J 9.6 Hz), 5.21 (d, 1 H,
J 4.0 Hz, a-H-1), 5.20–5.10 (m, 2 H, CH2ꢁ), 5.02 (t, 1
H, J 9.6 Hz), 5.00 (t, 1 H, J 9.2 Hz), 4.88 (t, 1 H, J 9.0
Hz), 4.81 (d, 1 H, J 8.0 Hz, b-H-1), 4.75 (dd, 1 H, J 3.8,
10.4 Hz, H-2%), 4.54 (d, 1 H, J 8.0 Hz, b-H-1), 4.28–
4.21 (m, 2 H), 4.17–4.16 (m, 2 H), 4.12–3.92 (m, 7 H),
3.77 (s, 3 H, CH3O), 3.67–3.59 (m, 2 H), 3.52 (t, 1 H,
J 9.2 Hz), 2.19, 2.11, 2.10, 2.09, 2.07, 2.06, 2.02, 2.00.
13C NMR (CDCl3): l 170.34, 170.25, 170.10, 170.07,
169.09, 169.27, 168.83, 168.64, 168.64, 168.37, 156.10,
151.2, 133.69, 118.06, 116.46, 114.14, 100.45 (b-C-1,
JC1ꢀH1 165 Hz), 100.19 (b-C-1, JC1ꢀH1 166 Hz), 94.93
(a-C-1, JC1ꢀH1 175 Hz), 79.52, 74.70, 74.57, 72.08, 71.92,
71.70, 71.56, 70.93, 70.13, 68.73, 67.54, 67.17, 61.59,
61.45, 61.08, 55.21, 20.95, 20.87, 20.76, 20.69, 20.66,
20.57, 20.42. Anal. Calcd for C46H60O26: C, 53.70; H,
5.84. Found: C, 53.57; H, 5.77.
3.5. 4-Methoxyphenyl 2,4,6-tri-O-acetyl-3-O-allyl-b-D-
glucopyranosyl-(13)-2,4,6-tri-O-acetyl-b-
D-gluco-
pyranoside (4b)
Donor 3 (2.50 g, 5 mmol) was coupled with acceptor 2
(2.10 g, 5 mmol) to give 4b (900 mg, 23%): [h]D −72.5°
1
(c 0.2, CHCl3); H NMR (CDCl3): l 6.92–6.79 (m, 4
H, C6H4), 5.74 (m, 1 H, ꢀCHꢁ), 5.29–5.11 (m, 3 H),
5.05 (t, 1 H, J 9.6 Hz), 5.02 (t, 1 H, J 9.2 Hz), 4.90 (t,
1 H, J 9.0 Hz), 4.81 (d, 1 H, J 8.0 Hz, b-H-1), 4.53 (d,
1 H, J 8.4 Hz, b-H-1), 4.30 (m, 1 H), 4.28–4.26 (m, 2